299 related articles for article (PubMed ID: 15856079)
1. Treatment enhances ultradian rhythms of CSF monoamine metabolites in patients with major depressive episodes.
Salomon RM; Kennedy JS; Johnson BW; Urbano Blackford J; Schmidt DE; Kwentus J; Gwirtsman HE; Gouda JF; Shiavi RG
Neuropsychopharmacology; 2005 Nov; 30(11):2082-91. PubMed ID: 15856079
[TBL] [Abstract][Full Text] [Related]
2. Central neurochemical ultradian variability in depression.
Salomon RM; Johnson BW; Schmidt DE
Dis Markers; 2006; 22(1-2):65-72. PubMed ID: 16410652
[TBL] [Abstract][Full Text] [Related]
3. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
[TBL] [Abstract][Full Text] [Related]
4. Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder.
Yoon HS; Hattori K; Ogawa S; Sasayama D; Ota M; Teraishi T; Kunugi H
J Clin Psychiatry; 2017; 78(8):e947-e956. PubMed ID: 28749090
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
[TBL] [Abstract][Full Text] [Related]
6. Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.
Vaughn DM; Smyth GB; Whitmer WL; Satjawatcharaphong C
Vet Res Commun; 1989; 13(3):237-49. PubMed ID: 2476887
[TBL] [Abstract][Full Text] [Related]
7. Monoamine metabolites level in CSF is related to the 5-HTT gene polymorphism in treatment-resistant depression.
Kishida I; Aklillu E; Kawanishi C; Bertilsson L; Agren H
Neuropsychopharmacology; 2007 Oct; 32(10):2143-51. PubMed ID: 17299512
[TBL] [Abstract][Full Text] [Related]
8. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.
Poceta JS; Parsons L; Engelland S; Kripke DF
Sleep Med; 2009 Jan; 10(1):129-33. PubMed ID: 18207455
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
De Bellis MD; Geracioti TD; Altemus M; Kling MA
Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):636-41. PubMed ID: 7687151
[TBL] [Abstract][Full Text] [Related]
10. Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling.
Geracioti TD; Loosen PT; Ekhator NN; Schmidt D; Chambliss B; Baker DG; Kasckow JW; Richtand NM; Keck PE; Ebert MH
Depress Anxiety; 1997; 6(3):89-94. PubMed ID: 9442982
[TBL] [Abstract][Full Text] [Related]
11. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
[TBL] [Abstract][Full Text] [Related]
12. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid.
Rogers J; Martin LJ; Comuzzie AG; Mann JJ; Manuck SB; Leland M; Kaplan JR
Biol Psychiatry; 2004 Apr; 55(7):739-44. PubMed ID: 15039003
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
Ogawa S; Tsuchimine S; Kunugi H
J Psychiatr Res; 2018 Oct; 105():137-146. PubMed ID: 30219563
[TBL] [Abstract][Full Text] [Related]
14. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
[TBL] [Abstract][Full Text] [Related]
15. Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient.
Janssens J; Atmosoerodjo SD; Vermeiren Y; Absalom AR; den Daas I; De Deyn PP
Neurochem Int; 2019 Sep; 128():154-162. PubMed ID: 31034914
[TBL] [Abstract][Full Text] [Related]
16. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Yoshino K
No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
[TBL] [Abstract][Full Text] [Related]
17. CSF monoamine metabolites in patients and controls: support for a bimodal distribution in major affective disorders.
Westenberg HG; Verhoeven WM
Acta Psychiatr Scand; 1988 Nov; 78(5):541-9. PubMed ID: 2466394
[TBL] [Abstract][Full Text] [Related]
18. Age and Gender-Related Changes in Biogenic Amine Metabolites in Cerebrospinal Fluid in Children.
Kuśmierska K; Szymańska K; Rokicki D; Kotulska K; Jóźwiak S; Sykut-Cegielska J; Mierzewska H; Szczepanik E; Pronicka E; Demkow U
Adv Exp Med Biol; 2016; 878():73-82. PubMed ID: 26453071
[TBL] [Abstract][Full Text] [Related]
19. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder.
Hou C; Jia F; Liu Y; Li L
Brain Res; 2006 Jun; 1095(1):154-8. PubMed ID: 16713589
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid monoamine metabolite concentrations as intermediate phenotypes between glutamate-related genes and psychosis.
Andreou D; Söderman E; Axelsson T; Sedvall GC; Terenius L; Agartz I; Jönsson EG
Psychiatry Res; 2015 Sep; 229(1-2):497-504. PubMed ID: 26142836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
